PubHawk
November 2021 PMID 34806296

Current approaches to HIV vaccine development: a narrative review.

Jiae Kim, Sandhya Vasan, Jerome H Kim, Julie A Ake

Download social card

Mentions

18
Peak: 4 in Jun 2023
across 4 sources since Dec 2021

Extended reach

20,464
potential audience

Total likes

140

Video views

11,373

Mentions per month

Dec 2021 – Sep 2025

Where it's discussed

  • X / Twitter12 posts
  • YouTube2 videos
  • News2 articles
  • Blogs2 articles

AI synopsis

What people are saying

The posts demonstrate a supportive view of the publication by referencing specific research efforts, such as the analysis of immune responses like ADCP and Env IgG3, and sharing updates on related studies, which shows a recognition of the ongoing scientific work. The tone remains neutral to slightly positive, emphasizing the importance of advancing vaccine strategies without expressing strong disagreement or excitement, thus reflecting moderate scores across all dimensions.

AgreementModerate agreement

Most discussions acknowledge the complexity of HIV vaccine development and agree on the challenges highlighted in the publication.

InterestModerate interest

The social discussions reflect a moderate level of interest, as participants show curiosity about the research findings but do not delve deeply into detailed scientific debate.

EngagementModerate engagement

While some posts mention the article and related research efforts, they tend to be brief, indicating a moderate level of engagement.

ImpactNeutral impact

The discussions indicate awareness of ongoing research efforts but do not suggest immediate or transformative impacts from the publication.

Abstract in brief

  • The development of an HIV vaccine faces major challenges due to the virus's biology and difficulties in testing vaccine effectiveness, with only one modest success to date from the RV144 trial.
  • Researchers have tried various approaches, including prime-boost strategies, mosaic antigens, new viral vectors, nucleic acid platforms, and potent adjuvants, to improve immune responses against HIV.
  • Lessons from past trials and research have led to innovative vaccine designs, creating a diverse pipeline of new candidates currently in early testing stages aimed at producing a globally effective HIV vaccine.]
Read the full abstract

Top posts

Most liked on X and Bluesky
Joshua
@Joshe20981273 · X

@iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 3 likes · 2 shares · 3,693 followers View post →
MHRP
@MHRPInfo · X

MHRP's COL Julie Ake, Dr. Sandhya Vasan, Dr. Jiae Kim and former MHRP Deputy Director, @drjeromekim1 recently published a supplement in the #JAIDS special on current approaches to #HIV vaccine development. More here: https://t.co/kkGMf3Xcm1 @HJFMilMed @wrair

Dec 2, 2021 · 2 likes · 1 share · 1,010 followers View post →
Sorina Durante
@SorinaDurante · X

RT @Joshe20981273: @iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 2 shares · 2,909 followers View post →
भारत की आवाज राजीव भाई दीक्षित
@DX47929066 · X

RT @Joshe20981273: @iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 2 shares · 865 followers View post →
INHCC
@neuroHIVcure · X

RT @MHRPInfo: MHRP's COL Julie Ake, Dr. Sandhya Vasan, Dr. Jiae Kim and former MHRP Deputy Director, @drjeromekim1 recently published a sup…

Dec 2, 2021 · 1 share · 230 followers View post →
Sabean Nicolai
@AmandaC45339328 · X

https://t.co/8h0aXFE9ZF

Feb 22, 2025 · 88 followers View post →

All mentions

Sabean Nicolai
@AmandaC45339328 · X

https://t.co/8h0aXFE9ZF

Feb 22, 2025 · 88 followers View post →
Oliver (08 +)
@owllms_ · X

Current approaches to HIV vaccine development: a narrative review "Post hoc analysis of HVTN 505 revealed that ADCP, binding to FcγRIIa, and HIV‐1 Env IgG3 correlated to reduced acquisition risk of HIV-1" https://t.co/aRAB2Wgnah

Jun 22, 2024 · 50 followers View post →
Sorina Durante
@SorinaDurante · X

RT @Joshe20981273: @iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 2 shares · 2,909 followers View post →
भारत की आवाज राजीव भाई दीक्षित
@DX47929066 · X

RT @Joshe20981273: @iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 2 shares · 865 followers View post →
Joshua
@Joshe20981273 · X

@iluminatibot https://t.co/AqAeYeJmEq

Aug 5, 2023 · 3 likes · 2 shares · 3,693 followers View post →
luxeradiancebeauty
@pbalachandran30 · X

@CDCgov https://t.co/mT4HQXlxEw

Jun 19, 2023 · 50 followers View post →
luxeradiancebeauty
@pbalachandran30 · X

@MoHFW_INDIA @PMOIndia @mansukhmandviya @DrBharatippawar @spsinghbaghelpr @PIB_India @DDNewslive @AmritMahotsav https://t.co/mT4HQXlxEw

Jun 19, 2023 · 50 followers View post →
luxeradiancebeauty
@pbalachandran30 · X

@TGAgovau https://t.co/mT4HQXlxEw

Jun 19, 2023 · 50 followers View post →
luxeradiancebeauty
@pbalachandran30 · X

@Mark_Butler_MP https://t.co/mT4HQXlxEw

Jun 19, 2023 · 50 followers View post →
Prometheus
@PrometheusClstr · X

New article: Current approaches to HIV vaccine development: a narrative review https://t.co/MtYJcSVqmM

Dec 13, 2021 · 31 followers View post →
INHCC
@neuroHIVcure · X

RT @MHRPInfo: MHRP's COL Julie Ake, Dr. Sandhya Vasan, Dr. Jiae Kim and former MHRP Deputy Director, @drjeromekim1 recently published a sup…

Dec 2, 2021 · 1 share · 230 followers View post →
MHRP
@MHRPInfo · X

MHRP's COL Julie Ake, Dr. Sandhya Vasan, Dr. Jiae Kim and former MHRP Deputy Director, @drjeromekim1 recently published a supplement in the #JAIDS special on current approaches to #HIV vaccine development. More here: https://t.co/kkGMf3Xcm1 @HJFMilMed @wrair

Dec 2, 2021 · 2 likes · 1 share · 1,010 followers View post →